Zolidronic acid and Charcot's foot
45,90 €*
Sofort verfügbar, Lieferzeit: 1-3 Tage
Produktnummer:
9786203968057
The objective of this study was to investigate the role of zoledronic acid in the treatment of diabetic Charcot foot. We enrolled 8 type 2 diabetic patients with Charcot neuroarthropathy. All our patients had a complete clinical examination and a podiatric examination. The stage of the neuroathropathy was evaluated. Zolidronic acid was administered to all patients at a dose of 4 mg/100 ml, as an intravenous infusion. We then evaluated the effectiveness of the treatment clinically and radiographically. The mean age of the patients was 61.4 years [55-64]. The mean time to onset of foot pain was 18.3 years [17-20]. The midfoot involvement was bilateral in 6 patients and unilateral in the other two. The neuroarthropathy was in the state phase of the Eichonholtz classification in 7 patients and in the acute phase in the 8th patient. Standard radiographs of the feet were all abnormal. We noted a disappearance of pain in 6 patients, an improvement of pain in one patient (VAS: decreased by 30%) and a persistence of mechanical pain in 1 patient (VAS 5).
| Autor: | Boussaid, Soumaya |
|---|---|
| EAN: | 9786203968057 |
| Sprache: | Englisch |
| Seitenzahl: | 56 |
| Produktart: | kartoniert, broschiert |
| Verlag: | Our Knowledge Publishing |
| Untertitel: | zolidronic acid in the management of Charcot foot: an alternative not to be ignored |
| Schlagworte: | Bisphosphonate Medizin diabetic foot zoledronic acid bisphosphonate |
| Größe: | 150 × 220 |
